Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.
Ontology highlight
ABSTRACT: Many lymphoid malignancies arise from deregulated c-MYC expression in cooperation with additional genetic lesions. While many of these cooperative genetic lesions have been discovered and their functions characterised, DNA sequence data of primary patient samples suggest that many more do exist. However, the nature of their contributions to c-MYC driven lymphomagenesis have not yet been investigated. We identified TFAP4 as a potent suppressor of c-MYC driven lymphoma development in a previous genome-wide CRISPR knockout screen in primary cells in vivo [1]. CRISPR deletion of TFAP4 in Eµ-MYC transgenic haematopoietic stem and progenitor cells (HSPCs) and transplantation of these manipulated HSPCs into lethally irradiated animals significantly accelerated c-MYC-driven lymphoma development. I
SUBMITTER: Potts MA
PROVIDER: S-EPMC10244435 | biostudies-literature | 2023 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA